GLP Chart Price Index.

The GLP Chart Price Index tracks the real maintenance-dose cash price of every US GLP-1 telehealth program in one place, dated and sourced. It exists because the advertised price is almost never what you pay at full dose, a gap we measured across every program, and because the all-in number for the whole market was not published anywhere else. It is built for patients comparing their options, and for journalists and researchers who need a figure they can cite, free to use under CC BY 4.0.

Every program, all-in, July 2026

One row per program. The figure is the all-in monthly cost at the program's published maintenance-dose pricing (membership, medication and fees together), the same number the homepage chart ranks by. Entry and starter rates never headline a row; where a program's cost steps up by dose, the row says so. Lock-in is the contract length required to avoid full price.

Swipe the table sideways for lock-in and score →

31 programs shown: 29 scored plus 2 manufacturer-direct pharmacies (marked Direct). Branded figures are cash-pay, no insurance applied; insurance-first programs are labeled. A ~ marks a maintenance estimate where the program publishes no full-dose price. The per-drug breakdown (47 price rows, including the $25/mo insurance copay routes) ships in the CSV with basis notes per row. Each program name links to our full review. Running your own numbers? Use the cost comparison calculator or the GLP-1 cost guide. For what reaches you locally, see the cheapest GLP-1 by state.

Download and cite this index

Published under Creative Commons CC BY 4.0. Reuse any number, chart row or download with attribution. The cheapest flat cash-pay GLP-1 program in July 2026 is $178/mo (GLP Chart, July 2026). Suggested citation:

For source-level documentation, email press@glpchart.com.

Price history

What each program advertised, June 2025 to June 2026, read off its own pricing page as archived on web.archive.org. Every point links to its snapshot.

The figures mean different things by program: an entry or starting figure is not the ongoing full-dose cost, and a membership fee leaves the medication out. Each card states its own basis. We did not track these months in real time; a month with no clean snapshot shows a gap. Our own maintenance series is the Monday tracker below.

Not charted: Form Health, Medvi, Lemonaid, Strut, Embla, 9am Health, Klarity, Lifeforce, Lindora and Push Health left no usable price trail in the public archive (their archived pages publish no consumer price), and Sesame and Calibrate have too few clean snapshots to draw a line. Knownwell and Found appear in the cards as branded list-price references, not program costs.

Every check is logged. Full dated record: price change log.

How we built this

Every price is verified against the program's published pricing page, or the published target-dose tier for tiered-dose programs. We check every Monday, with off-cycle checks when something needs attention. When a program's site blocks automated access, we confirm the figure through a web search of the program's own materials. We do not create accounts or make any purchase. If a price is a range, we report the range. For programs with separate cash-pay and insurance rails, we report cash-pay only. Insurance copays depend on plan terms, not program terms. The dataset refreshes monthly with the month tag in the file name. The table above always reflects the latest dated check. Full scoring methodology and sub-score definitions: methodology.

Frequently asked questions

How do compounded and branded GLP-1 prices compare, drug by drug? See the data study →

John Samaras, Founder and EditorI started GLP Chart after overpaying for a GLP-1 myself. Based in Austin, Texas.
About this site · LinkedIn · Contact